DBTX News

The IPO frenzy continued this past week as 17 IPOs and 26 SPACs entered the public market. Headlining the week were dating app Bumble (BMBL), which completed the year's largest deal so far, and Chinese cloud services provider Cloopen Group (RAAS), which bagged the biggest pop of 2021 to date. Bumble (BMBL) priced further...read more

Decibel Therapeutics, which is developing preclinical gene therapies for hearing loss and balance disorders, raised $127 million by offering 7.1 million shares at $18, the high end of the range of $16 to $18. The company had originally filed to sell 5.9 million shares. Decibel Therapeutics plans to list on the Nasdaq under the symbol DBTX. Citi, SVB Leerink, BMO Capital Markets...read more

Decibel Therapeutics, a Phase 1 biotech developing treatments for hearing and balance disorders, announced terms for its IPO on Monday. The Boston, MA-based company plans to raise $100 million by offering 5.9 million shares at a price range of $16 to $18. At the midpoint of the proposed range, Decibel Therapeutics would command a fully diluted market value of $427 million. ...read more

Decibel Therapeutics, a Phase 1 biotech developing treatments for hearing and balance disorders, filed on Friday with the SEC to raise up to $75 million in an initial public offering. Decibel Therapeutics aims to restore and improve hearing and balance through the restoration and regeneration of functional hair cells and non-sensory support cells within the inner ear....read more